Medication info
Candesartan 8mg (Candesartan Cilexetil)

Candesartan 8mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
Pale pink, round tablet with a biconvex shape on both sides
Packaging
30 tablets/bottle, 100 tablets/bottle, 30 tablets (10 tablets/PTP*3, for export)
Approval status
Active

MFDS item code 200908348 · Notified 2009.11.27 · Insurance code 649805030

Summary

Main use
Treatment of essential hypertension and heart failure with impaired left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Pediatric patients: The safety and efficacy of this medicine have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Pediatric patients: The safety and efficacy of this medicine have not been established in adolescents and children aged 18 years or younger.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with impaired left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used for essential hypertension in patients with high blood pressure and for heart failure patients with impaired left ventricular systolic function. It is especially for patients classified as NYHA class II ~ IV with a left ventricular ejection fraction of 40% or less, who require additional therapy to ACE inhibitors or cannot use ACE inhibitors. This drug helps in effectively controlling blood pressure and alleviating symptoms of heart failure. Treatment reduces the burden on the heart and improves the overall cardiovascular condition of the patient. It is important for patients to maintain regular use and receive regular medical check-ups.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Pediatric patients: The safety and efficacy of this medicine have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Pediatric patients: The safety and efficacy of this medicine have not been established in adolescents and children aged 18 years or younger.

Precautions

This medication can cause serious damage to the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Individuals with allergies to this medication or any of its components, pregnant women or those who may become pregnant, breastfeeding women, those with severe liver disease or cholestasis, and individuals with certain hereditary diseases should not use this medication. Elderly patients, those with elevated potassium levels, patients with liver diseases, those with heart valve abnormalities, and patients with poor kidney function should use this medication cautiously and require regular monitoring. During the use of this medication, symptoms such as dizziness, back pain, and respiratory infections may occur, and serious side effects may rarely occur, so patients should consult a healthcare professional immediately if any unusual symptoms occur. In heart failure patients, side effects such as hypotension, hyperkalemia, and worsening kidney function may occur, necessitating regular blood tests and monitoring of condition. When taken in combination with other antihypertensive medications, the blood pressure lowering effect may be amplified, so caution is required upon concomitant use. When used alongside potassium-sparing diuretics or potassium supplements, dangerously elevated blood potassium levels may occur, so caution is needed. This medication can be taken regardless of meals and generally has minimal drug interactions, but caution is required when used alongside certain medications. This medication should not be administered to pregnant or breastfeeding women, and if there are plans to become pregnant or if already pregnant, it is imperative to inform the healthcare provider. The safety and effectiveness for children and adolescents under 18 years of age have not been established, and it is recommended not to use it in this population. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may present, and in such cases, immediate medical attention should be sought. This medication should be stored out of reach of children and should not be transferred to other containers for safety. Dizziness or drowsiness may occur when driving or operating machinery, so caution is necessary.

Side effects

  • dizziness
  • back pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • asthenia
  • fever
  • sensory disturbances
  • dyspepsia
Show 60 more
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • increased creatinine
  • increased urea
  • leukopenia in blood and lymphatic system
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • headache
  • intestinal vascular edema
  • nausea
  • diarrhea
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • arthralgia
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • tension increase
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorders
  • decreased libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste distortion
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. Additionally, it is advisable to keep the medication at room temperature between 1 to 30 degrees Celsius, rather than in excessively hot or cold places.

Appearance and packaging

Appearance

Pale pink, round tablet with a biconvex shape on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle, 30 tablets (10 tablets/PTP*3, for export)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.